Almirall – Digital Transformation Strategies
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Almirall is a global biopharmaceutical company specializing in dermatology. The company develops and commercializes solutions for the treatment of a variety of dermatological diseases such as acne, atopic dermatitis, actinic keratosis, vitiligo, onychomycosis, skin cancer, and psoriasis, among others. Some of the company’s key products are Wynora cream (for mild-to-moderate plaque psoriasis), Skilarence (for moderate-to-severe plaque psoriasis), and Actikerall (for hyperkeratotic actinic keratosis). The company also produces medicines for neurological, gastric, and cardiac diseases. The company sells a total of 143 products, of which 51 are for skin diseases.
The report provides information and insights into Almirall's tech activities, including –
• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships and product launches.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets and major ICT contracts.
Scope
The report provides insights into the company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Reasons to Buy
• Gain insights into Almirall's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches and partnerships.
Barcelona Supercomputing Center-Centro Nacional de Supercomputación (BSC-CNS)
Nostrum Biodiscovery
NTT Data
ZeClinics
Absci Corporation
Aktana
Iktos
Clariba
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals and Healthcare reports